DuoTrav® Eye Drops As Replacement Therapy Program
NCT00828906 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 128
Last updated 2012-09-20
Summary
To evaluate the effectiveness of DuoTrav Eye Drops in gaining or maintaining control of target Intraocular Pressures (tIOP) in patients diagnosed with, and being treated for, open-angle glaucoma (OAG) or ocular hypertension (OH).
Conditions
- Open-angle Glaucoma
- Ocular Hypertension
Interventions
- DRUG
-
DuoTrav
DuoTrav Eye Drops
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2009-11-30
Countries
- China
Study Locations
More Related Trials
-
Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure
NCT02003391 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia
NCT01696383 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00293761 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of DuoTrav APS Versus DuoTrav
NCT00862472 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
NCT01336569 ·Status: COMPLETED ·Phase: PHASE4
-
DuoTrav APS Versus XALACOM® in Ocular Surface Health
NCT00912054 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00333125 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00672997 ·Status: COMPLETED ·Phase: PHASE3
-
Anecortave Acetate in Patients With Open-angle Glaucoma
NCT00320203 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
NCT01514721 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy Study of Travoprost APS Versus TRAVATAN
NCT00848536 ·Status: COMPLETED ·Phase: PHASE3
-
Glaucoma Adherence Study
NCT00676637 ·Status: COMPLETED
-
A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma
NCT00887029 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Travoprost/Timolol BAC-free
NCT00760539 ·Status: COMPLETED ·Phase: PHASE3
-
Divided Dose of TRAVATAN®
NCT01298687 ·Status: COMPLETED ·Phase: PHASE2
-
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00527501 ·Status: COMPLETED ·Phase: PHASE2
-
Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav
NCT00519753 ·Status: COMPLETED ·Phase: PHASE4
-
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension
NCT06152861 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
NCT00966940 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00293800 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
NCT02829996 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of a Glaucoma Drug Delivery System
NCT00824720 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT00051142 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00293787 ·Status: COMPLETED ·Phase: PHASE3
-
Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
NCT00763061 ·Status: COMPLETED ·Phase: PHASE4